GlobalData

This new fund is part of a series of supportive steps Japan took over the past few years to enhance its pharmaceutical sector…

GlobalData’s report reveals that CGT market for GI disorders, as a standalone therapy area, is expected to increase from $47…

GlobalData’s bio/pharmaceutical outsourcing report highlights the reliance of smaller pharma companies on CDMOs for production,…

CRD-38’s alternative mechanism positions it as a potential new option in heart failure treatment

Sionna’s IPO signals investor interest amid competitive cystic fibrosis treatment landscape

Targeted therapies poised to transform Fragile X syndrome market with 4X growth by 2030

Oral eosinophilic asthma therapy nears Phase 3 completion, with results set to shape future treatment pathways

Johnson & Johnson, Eli Lilly, and Gilead Sciences lead M&A activity; Venture capital investments increase by 62.1 per cent…

Consolidation has emerged as a major trend as the pharma industry seeks new avenues of growth and looks to expand its existing…

The industry’s outlook remains uncertain as it navigates complex economic and political dynamics, reveals GlobalData